0001773751-24-000057.txt : 20240307
0001773751-24-000057.hdr.sgml : 20240307
20240307201058
ACCESSION NUMBER: 0001773751-24-000057
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240305
FILED AS OF DATE: 20240307
DATE AS OF CHANGE: 20240307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Baird Melissa
CENTRAL INDEX KEY: 0001837815
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38986
FILM NUMBER: 24732021
MAIL ADDRESS:
STREET 1: 2269 CHESTNUT STREET, #523
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94123
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Hims & Hers Health, Inc.
CENTRAL INDEX KEY: 0001773751
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2269 CHESTNUT ST
STREET 2: #523
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94123
BUSINESS PHONE: 415-851-0195
MAIL ADDRESS:
STREET 1: 2269 CHESTNUT ST
STREET 2: #523
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94123
FORMER COMPANY:
FORMER CONFORMED NAME: Oaktree Acquisition Corp.
DATE OF NAME CHANGE: 20190412
4
1
wk-form4_1709860250.xml
FORM 4
X0508
4
2024-03-05
0
0001773751
Hims & Hers Health, Inc.
HIMS
0001837815
Baird Melissa
2269 CHESTNUT STREET, #523
SAN FRANCISCO
CA
94123
0
1
0
0
Chief Operating Officer
1
Class A Common Stock
2024-03-05
4
M
0
6715
0.40
A
514180
D
Class A Common Stock
2024-03-05
4
M
0
5036
0.40
A
519216
D
Class A Common Stock
2024-03-05
4
S
0
6715
14.2158
D
512501
D
Class A Common Stock
2024-03-05
4
S
0
5036
14.2183
D
507465
D
Class A Common Stock
2024-03-06
4
M
0
5036
0.40
A
512501
D
Class A Common Stock
2024-03-06
4
M
0
6715
0.40
A
519216
D
Class A Common Stock
2024-03-06
4
S
0
5036
13.9881
D
514180
D
Class A Common Stock
2024-03-06
4
S
0
6715
13.986
D
507465
D
Class A Common Stock
2024-03-07
4
M
0
5036
0.40
A
512501
D
Class A Common Stock
2024-03-07
4
M
0
6715
0.40
A
519216
D
Class A Common Stock
2024-03-07
4
S
0
6715
14.358
D
512501
D
Class A Common Stock
2024-03-07
4
S
0
5036
14.3507
D
507465
D
Stock Option (right to buy)
0.40
2024-03-05
4
M
0
6715
0
D
2028-03-28
Class A Common Stock
6715
803949
D
Stock Option (right to buy)
0.40
2024-03-05
4
M
0
5036
0
D
2028-03-28
Class A Common Stock
5036
798913
D
Stock Option (right to buy)
0.40
2024-03-06
4
M
0
5036
0
D
2028-03-28
Class A Common Stock
5036
793877
D
Stock Option (right to buy)
0.40
2024-03-06
4
M
0
6715
0
D
2028-03-28
Class A Common Stock
6715
787162
D
Stock Option (right to buy)
0.40
2024-03-07
4
M
0
6715
0
D
2028-03-28
Class A Common Stock
6715
780447
D
Stock Option (right to buy)
0.40
2024-03-07
4
M
0
5036
0
D
2028-03-28
Class A Common Stock
5036
775411
D
The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person.
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $13.96 - $14.47. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $13.99 - $14.475. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $13.55- $14.17. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $13.72 - $14.15. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.13- $14.66. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.08 - $14.54. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested.
/s/ Alexandra Cotter Wilkins, Attorney-in-Fact
2024-03-07